AbCellera Biologics Inc. ABCL Increase Decrease In Accrued Income Taxes Payable
Increase Decrease In Accrued Income Taxes Payable at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable.
The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s increase decrease in accrued income taxes payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s increase decrease in accrued income taxes payable?
- AbCellera Biologics Inc. (ABCL) reported increase decrease in accrued income taxes payable of -$4.97M in Q1 2026.
- How has AbCellera Biologics Inc.'s increase decrease in accrued income taxes payable changed year-over-year?
- AbCellera Biologics Inc.'s increase decrease in accrued income taxes payable decreased by 12.7% year-over-year, from -$4.41M to -$4.97M.
- What is the long-term trend for AbCellera Biologics Inc.'s increase decrease in accrued income taxes payable?
- Over 3 years (2022 to 2025), AbCellera Biologics Inc.'s increase decrease in accrued income taxes payable has grown at a -30.4% compound annual growth rate (CAGR), from -$88.61M to -$29.84M.
- What does increase decrease in accrued income taxes payable mean?
- This tracks the change in the company's tax liabilities that have been incurred but not yet paid to tax authorities. It provides insight into the timing of tax payments and the company's current tax position relative to its reported earnings. Significant fluctuations can indicate changes in tax planning strategies or the timing of tax settlements.